Trial of Rituximab for Graves' Ophthalmopathy

NCT00595335 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Thyroid-associated Ophthalmopathy

Interventions

DRUG: Rituximab
DRUG: Saline
DRUG: Methylprednisolone

Sponsor

Rebecca Bahn

Collaborators

[object Object]
[object Object]